INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 58 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,364 | +31.6% | 158,500 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $25,360 | -71.2% | 158,500 | 0.0% | 0.00% | -72.7% |
| Q4 2022 | $87,968 | -73.3% | 158,500 | +8.4% | 0.01% | -77.1% |
| Q4 2021 | $329,000 | -34.2% | 146,200 | 0.0% | 0.05% | -42.2% |
| Q3 2021 | $500,000 | +37.4% | 146,200 | +20.0% | 0.08% | +31.7% |
| Q2 2021 | $364,000 | +134.8% | 121,800 | +66.4% | 0.06% | +96.9% |
| Q4 2020 | $155,000 | – | 73,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,766,508 | $19,826,000 | 2.39% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,286,032 | $2,610,000 | 0.07% |
| Clear Harbor Asset Management, LLC | 153,800 | $312,000 | 0.06% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 219,652 | $445,000 | 0.03% |
| Rock Springs Capital Management LP | 270,000 | $548,000 | 0.02% |
| Alambic Investment Management, L.P. | 77,665 | $158,000 | 0.02% |
| Marshall Wace North America L.P. | 1,173,515 | $2,382,000 | 0.01% |
| Baker Brothers Advisors | 580,400 | $1,178,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $932,000 | 0.01% |
| Intellectus Partners, LLC | 13,000 | $26,000 | 0.01% |